These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19823894)

  • 1. Magnetization transfer imaging in 'premanifest' Huntington's disease.
    Jurgens CK; Bos R; Luyendijk J; Witjes-Ané MN; van der Grond J; Middelkoop HA; Roos RA
    J Neurol; 2010 Mar; 257(3):426-32. PubMed ID: 19823894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.
    Henley SM; Wild EJ; Hobbs NZ; Scahill RI; Ridgway GR; Macmanus DG; Barker RA; Fox NC; Tabrizi SJ
    J Neurol; 2009 Feb; 256(2):203-12. PubMed ID: 19266143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetization transfer imaging in premanifest and manifest Huntington disease.
    van den Bogaard SJ; Dumas EM; Milles J; Reilmann R; Stout JC; Craufurd D; van Buchem MA; van der Grond J; Roos RA
    AJNR Am J Neuroradiol; 2012 May; 33(5):884-9. PubMed ID: 22241387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up.
    van den Bogaard SJ; Dumas EM; Hart EP; Milles J; Reilmann R; Stout JC; Craufurd D; Gibbard CR; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA
    AJNR Am J Neuroradiol; 2013 Feb; 34(2):317-22. PubMed ID: 22918430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and neuropathology of Huntington's disease.
    Reiner A; Dragatsis I; Dietrich P
    Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
    Panegyres PK; Goh JG
    J Neurol Sci; 2011 Feb; 301(1-2):14-20. PubMed ID: 21147489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal ganglia volume is strongly related to P3 event-related potential in premanifest Huntington's disease.
    Jurgens CK; van der Hiele K; Reijntjes RH; van de Wiel L; Witjes-Ané MN; van der Grond J; Roos RA; Middelkoop HA; van Dijk JG
    Eur J Neurol; 2011 Aug; 18(8):1105-8. PubMed ID: 21749577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neurofilament heavy chain levels in Huntington's disease.
    Wild EJ; Petzold A; Keir G; Tabrizi SJ
    Neurosci Lett; 2007 May; 417(3):231-3. PubMed ID: 17363167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.
    Wu D; Faria AV; Younes L; Mori S; Brown T; Johnson H; Paulsen JS; Ross CA; Miller MI;
    Hum Brain Mapp; 2017 Oct; 38(10):5035-5050. PubMed ID: 28657159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.
    Verny C; Allain P; Prudean A; Malinge MC; Gohier B; Scherer C; Bonneau D; Dubas F; Le Gall D
    Eur J Neurol; 2007 Dec; 14(12):1344-50. PubMed ID: 17941857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
    Tabrizi SJ; Langbehn DR; Leavitt BR; Roos RA; Durr A; Craufurd D; Kennard C; Hicks SL; Fox NC; Scahill RI; Borowsky B; Tobin AJ; Rosas HD; Johnson H; Reilmann R; Landwehrmeyer B; Stout JC;
    Lancet Neurol; 2009 Sep; 8(9):791-801. PubMed ID: 19646924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlates of mitochondrial function in Huntington's disease muscle.
    Turner C; Cooper JM; Schapira AH
    Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation-related magnetization-transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra-strong gradient MRI.
    Casella C; Chamberland M; Laguna PL; Parker GD; Rosser AE; Coulthard E; Rickards H; Berry SC; Jones DK; Metzler-Baddeley C
    Hum Brain Mapp; 2022 Aug; 43(11):3439-3460. PubMed ID: 35396899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.